The initial Cochrane assessment on this subject matter (Yelland 2004B) was performed to focus exclusively on prolotherapy injections, following an before Cochrane assessment of all injection therapies for minimal‐back pain (Nelemans 2003) by which the one treatment that showed sizeable, sustained reductions in pain and incapacity at 6 months https://proleviate.com/use-conolidine-for-back-pain/